合成药物和与OAT3相互作用的天然活性物的最新进展
Ying Chen1,2, Hongyan Li1,2, Ke Wang1,2
1Key Laboratory of Geriatric Nutrition and Health, Ministry of Education, Beijing Technology and Business University, Beijing 100048, China.
Molecules (Basel, Switzerland)
|June 28, 2023
概括
有机离子载体3 (OAT3) 影响药物清除. 本综述涵盖了OAT3介导的药物药物和草药药物相互作用,为安全的同时使用和抑制剂查提供了见解.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药物新陈代谢 药物新陈代谢
背景情况:
- 有机离子载体3 (OAT3) 主要位于脏中.
- OAT3对于消除各种药物和内源性化合物至关重要.
- 涉及OAT3的相互作用可以显著影响药物的药理动力学.
研究的目的:
- 审查通过OAT3.3调解的药物相互作用 (DDI) 和草药相互作用 (HDI).
- 为了确定抑制OAT3活性的天然化合物.
- 为提供关于OAT3基质同时使用的临床实践提供参考.
主要方法:
- 关于过去十年发表的研究的文献综述.
- 专注于涉及OAT3基质的相互作用.
- 对作为OAT3抑制剂的天然化合物的分析.
主要成果:
- OAT3调解了许多DDI和HDI.
- 一些天然活性化合物已被确定为OAT3抑制剂.
- 了解这些相互作用对于预测药理动力学变化至关重要.
结论:
- 同时服用OAT3基质可以改变药物的药理动力学.
- 自然化合物可以抑制OAT3,导致潜在的相互作用.
- 本综述作为安全药物使用和OAT3抑制剂查的指南.
相关概念视频
Adrenergic Agonists: Indirect-Acting Agents
1.7K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.7K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
267
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
267
Drug-Receptor Interaction: Agonist
2.6K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.6K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
347
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
347


